Phosphatidylethanol as an objective measure of heavy drinking days in a clinical trial for alcohol use disorder.
Our findings support the use of PEth as an objective measure of heavy drinking days in a clinical setting. Further research is needed to validate these findings in larger cohorts.
Authors
- Anders Fink‐Jensen (ORCID: https://orcid.org/0000-0001-7143-1236)
- Mathias E. Jensen (ORCID: https://orcid.org/0000-0002-2555-4785)
- TINA VILSBØLL
- M Bergmann (ORCID: https://orcid.org/0000-0001-9213-3676)
- Christophe Pol Stove (ORCID: https://orcid.org/0000-0001-7126-348X)
- Mette Kruse Klausen (ORCID: https://orcid.org/0000-0002-9300-470X)
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- University of Southern Denmark (DK)
- Frederiksberg Hospital (DK)
- Ghent University (BE)
- Region of Southern Denmark (DK)
Publication Details
- Journal
- PubMed
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1093/alcalc/agag001
- Primary Topic
- Substance Abuse Treatment and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00